Ординатура / Офтальмология / Английские материалы / Oxford American Handbook of Ophthalmology_Tsai, Denniston, Murray_2011
.pdf726 |
INDEX |
|
|
|
|
|
optic nerve hypoplasia, 535 |
retention cyst, 153 |
herpes simplex keratitis, |
|
|
tilted disc, 535 |
toxic conjunctivitis, 152 |
174–6 |
|
|
Congenital rubella, 619 |
viral conjunctivitis, 142–3 |
herpes zoster |
|
|
clinical features of, 620 |
adenovirus, 142 |
ophthalmicus, 177–8 |
|
|
Congenital stationary night |
molluscum contagiosum, |
keratoplasty |
|
|
blindness (CSNB), 458 |
142–3 |
complications, 207–8 |
|
|
Congenital syphilis, 619 |
herpes simplex, 143 |
principles, 205–6 |
|
|
clinical features of, 620 |
Conjunctival intraepithelial |
microbial keratitis |
|
|
Congenital toxoplasmosis, |
neoplasia, 156 |
acanthamoeba, 170–2 |
|
|
619 |
Conjunctival Kaposi |
assessment, 166 |
|
|
clinical features of, 620 |
sarcoma, 157 |
treatment, 168–9 |
|
|
Congruousness, 48 |
Conjunctival lymphoma, 157 |
neurotrophic keratopathy, |
|
|
Conjunctiva, 106 |
Conjunctival |
200 |
|
|
allergic conjunctivitis, 146–7 |
microvasculopathy, 349 |
ophthalmic signs, 666–7 |
|
|
atopic |
Conjunctival nevus, 154 |
peripheral corneal |
|
|
keratoconjunctivitis, |
Conjunctival squamous cell |
diseases |
|
|
147 |
carcinoma, 156–7 |
dellen, 199 |
|
|
seasonal and |
Connective tissue disease, |
marginal keratitis, 198 |
|
|
perennial allergic |
631 |
phlyctenulosis, 198–9 |
|
|
rhinoconjunctivitis, |
Connective tissues |
rosacea associated |
|
|
146 |
disorders, 643 |
keratitis, 198 |
|
|
vernal |
Consecutive exotropia, 587 |
Terrien’s marginal |
|
|
keratoconjunctivitis, |
Contact lenses |
degeneration, 199 |
|
|
146–7 |
complications, 215–16 |
peripheral ulcerative |
|
|
anatomy and physiology, |
fitting, 213–14 |
keratitis, 195–7 |
|
|
136 |
nonrefractive contact |
physiology, 160–1 |
|
|
macroscopic, 136 |
lenses, 214 |
recurrent erosion |
|
|
microscopic, 136 |
refractive contact lenses, |
syndrome, 180 |
|
|
tear film, 136 |
213–14 |
refractive surgery, 209–10 |
|
|
bacterial conjunctivitis, 140 |
lens notation, 212 |
Thygeson’s superficial |
|
|
acute, 140 |
material, 211–12 |
punctate keratopathy, |
|
|
gonococcus, 140–1 |
hard lenses, 211 |
179 |
|
|
chlamydial conjunctivitis, |
hydrogel (soft), 211 |
Corneal degenerative |
|
|
144–5 |
rigid gas permeable, 211 |
disease, 181–2, 183–4 |
|
|
adult inclusion |
silicone hydrogel, 212 |
arcus, 181 |
|
|
conjunctivitis, 144 |
wearing schedule, 212 |
band keratopathy, 183 |
|
|
trachoma, 144–5 |
Continuous curvilinear |
cornea farinata, 181 |
|
|
cicatricial conjunctivitis, |
capsulorhexis, 242–3 |
crocodile shagreen, 181 |
|
|
148–9 |
Contrast sensitivity, 11 |
primary lipid keratopathy, |
|
|
primary, 148–9 |
Conventional vs. disposable |
181 |
|
|
secondary, 149 |
lenses, 212 |
Salzmann nodular |
|
|
clinical features, 139 |
Copper foreign body, 96 |
degeneration, 183–4 |
|
|
concretions, 153 |
Cornea, 600 |
secondary lipid |
|
|
conjunctival signs, 137 |
anatomy, 160–1 |
keratopathy, 181–2 |
|
|
keratoconjunctivitis sicca, |
contact lenses |
Vogt’s limbal girdle, 181 |
|
|
150–1 |
complications, 215–16 |
Corneal diagrams, 164 |
|
|
ligneous conjunctivitis, 152 |
fitting, 213–14 |
Corneal dystrophies |
|
|
nonpigmented conjunctival |
outline, 211–12 |
anterior, 185–6 |
|
|
lesions, 156–7 |
corneal degenerative |
epithelial basement |
|
|
benign, 156 |
disease, 181–2, 183–4 |
membrane |
|
|
malignant, 156–7 |
corneal diagrams, 164 |
dystrophy, 185 |
|
|
premalignant, 156 |
corneal dystrophies |
Meesman’s dystrophy, |
|
|
ophthalmic signs, 665 |
anterior, 185–6 |
185–6 |
|
|
Parinaud’s oculoglandular |
posterior, 191–2 |
Reis–Buckler dystrophy, |
|
|
syndrome, 152 |
stromal, 187–8, 189–90 |
185 |
|
|
pigmented conjunctival |
corneal ectasias, 193–4 |
central cloudy dystrophy, |
|
|
lesions, 154–5 |
corneal signs, 162–3 |
190 |
|
|
benign, 154 |
deposition keratopathies, |
fleck dystrophy, 190 |
|
|
malignant, 155 |
203 |
posterior, 191–2 |
|
|
premalignant, 154 |
exposure keratopathy, |
congenital hereditary |
|
|
pinguecula, 152 |
201–2 |
endothelial |
|
|
pterygium, 152–3 |
fungal keratitis, 172–3 |
dystrophy, 192 |
|
|
INDEX |
727 |
|
Fuchs’ endothelial |
Crowding, 7 |
mucopolysaccharidosis |
|
|
dystrophy, 191–2 |
Cryptococcus choroiditis, |
keratopathy, 203 |
|
|
posterior amorphous |
353 |
vortex keratopathy, 203 |
|
|
dystrophy, 190 |
Cryptophthalmos, 124 |
Wilson’s disease, 203 |
|
|
posterior polymorphous |
Crystalens, 238 |
Deprivation amblyopia, 576 |
|
|
dystrophy, 192 |
Crystalline keratopathies, |
Dermatochalasis, 122 |
|
|
stromal, 187–8, 189–90 |
203 |
Dermoids, 485 |
|
|
avellino dystrophy, 188 |
infectious, 203 |
cyst, 485 |
|
|
congenital hereditary |
mucopolysaccharidosis, |
Descemet’s membrane, 160 |
|
|
stromal dystrophy, |
203 |
Descemet’s stripping |
|
|
|
|
|||
189 |
Cyclic esotropia, 585 |
endothelial keratoplasty |
|
|
granular dystrophy, |
Cyclodiode, 297 |
(DSEK), 206 |
|
|
187–8 |
Cyclopentolate, 178, 325 |
Developmental |
|
|
lattice dystrophy types, |
Cyclophosphamide, 335, |
abnormalities, 635–7 |
|
|
187 |
709, 710 |
Devic’s disease, 523 |
|
|
macular dystrophy, 189 |
Cycloplegia, 100–1, 168, |
Dexamethasone, 100–1, |
|
|
Schnyder’s crystalline |
174–5, 175–6, 176 |
147, 147, 198, 254, 285, |
|
|
dystrophy, 189 |
Cyclosporine, 147, 335, |
325, 429 |
|
|
Corneal ectasias, 193–4 |
338, 340, 342, 344, |
Diabetes and cataract |
|
|
keratoconus, 193–4 |
709, 710 |
surgery, 249 |
|
|
keratoglobus, 194 |
Cystic lesions |
Diabetes Control and |
|
|
pellucid marginal |
cephalocele, 486 |
Complication Trial |
|
|
degeneration, 194 |
dacryops, 485 |
(DCCT), 419 |
|
|
posterior keratoconus, |
dermoid cyst, 485 |
Diabetic eye disease |
|
|
194 |
mucocele, 485–6 |
assessment, 420, 421 |
|
|
Corneal foreign bodies and |
Cystoid macular edema |
definitions in, 422 |
|
|
abrasions, 99 |
(CME), 429, 430 |
general, 418–19 |
|
|
Corneal imaging techniques, |
Cytomegalovirus (CMV), |
laser procedures in, 466–7 |
|
|
68–70 |
346 |
management |
|
|
anterior segment OCT, 69 |
retinitis, 352 |
recommendations |
|
|
confocal scanning laser |
D |
for, 425 |
|
|
ophthalmoscopy, 70 |
management, 423–4 |
|
|
|
corneal topography, 68 |
screening, 425 |
|
|
|
corneal ultrasonic |
Daclizumab, 370 |
Diagnosis, aids to |
|
|
pachymetry, 69 |
Dacryoadenitis, 484 |
acute red eye, 648 |
|
|
scanning-slit |
Dacryocystitis |
anisocoria, 659–60 |
|
|
videokeratography, 68 |
acute, 134 |
diplopia, 657–8 |
|
|
Scheimpflug camera, 69 |
chronic, 134 |
flashes and floaters, 654 |
|
|
Corneal infiltrate culture, 167 |
Dacryocystography (DCG), |
gradual loss of vision, |
|
|
Corneal iron lines |
75 |
651–2 |
|
|
ophthalmic signs, 666 |
Dacryocystorhinostomy |
headache, 655–6 |
|
|
Corneal scrapes, |
(DCR), 133 |
ophthalmic signs |
|
|
microbiological |
Dacryops, 485 |
anterior segment, 665–6 |
|
|
processing of, 167 |
Daily wear vs. extended |
external, 663–4 |
|
|
Corneal signs, 162–3 |
wear lenses, 212 |
posterior segment, |
|
|
endothelial signs, 163 |
Dark adaptometry, 74 |
671–2 |
|
|
epithelial signs, 162 |
Deep lamellar endothelial |
visual fields, 675–6 |
|
|
iron lines, 162 |
keratoplasty (DLEK), 206 |
nystagmus, 661–2 |
|
|
stromal signs, 163 |
Deep lamellar keratoplasty |
sudden or recent loss of |
|
|
Corneal topography, 68 |
(DLK), 206 |
vision, 649–50 |
|
|
Corneal transparency, |
superficial lamellar |
watery eye, 653 |
|
|
160–1 |
keratoplasty, 206 |
Didanosine, 438 |
|
|
Corneal ultrasonic |
Deferoxamine, 437–8 |
Diethylcarbamazine, 365 |
|
|
pachymetry, 69 |
Degenerative myopia, 431 |
Diffuse choroidal |
|
|
Corrected pattern standard |
Deletion syndromes, 638 |
hemangioma, 501 |
|
|
deviation (CPSD), 54 |
Dellen, 199 |
Diffuse non-necrotizing |
|
|
Corticosteroids, 335, 342, |
Demyelinating optic neuritis, |
scleritis, 221 |
|
|
563, 700 |
522–3 |
Diffuse unilateral subacute |
|
|
Cotrimoxazole, 362 |
Deposition keratopathies, |
neuroretinitis (DUSN), |
|
|
Cover–uncover test, 30 |
203 |
365 |
|
|
Cranial nerves III, IV, and |
crystalline keratopathies, |
Diplopia, 310, 578, 657–8, |
|
|
VI, 517 |
203 |
682 |
|
|
|
|
INDEX |
729 |
|
Fluorescein angiography |
Glaucoma |
Glycosaminoglycan |
|
|
(FA), 323, 60–2 |
anatomy, 262–3 |
metabolism disorders, |
|
|
contraindications, 60–2 |
assessment, 264 |
642 |
|
|
indications, 60–2 |
and cataract surgery, 249 |
Goldmann 3-mirror lens, 24 |
|
|
interpretation, 60–2 |
in children, 630–1 |
Goldmann perimetry, 50, |
|
|
method, 60–2 |
causes, 630–1 |
51–2 |
|
|
reporting on, 62 |
clinical features, 631 |
calibrating, 51–2 |
|
|
side effects, 60–2 |
treatment, 631 |
interpretation, 51–2 |
|
|
Fluoromethalone, 146, 147 |
chronic glaucoma diseases, |
method, 51–2 |
|
|
Fluoroquinolones, 168 |
276 |
results, 51–2 |
|
|
5-Fluorouracil (5-FU), |
filtration surgery |
Goldmann–Weekers |
|
|
289, 302 |
antimetabolites, 302 |
adaptometry, 74 |
|
|
Flurbiprofen, 221 |
complications, 304–5 |
Gonioscopy, 24–5 |
|
|
Focimetry, 44–5 |
trabeculectomy, 299–301 |
Shaffer classification, 20 |
|
|
automated focimetry, 44 |
glaucoma drainage device |
Spaeth classification, 20 |
|
|
manual focimetry, 44 |
surgery, 308–9 |
Gonococcal neonatal |
|
|
Fomivirsen, 347 |
iatrogenic glaucoma, |
conjunctivitis, 621 |
|
|
Foscarnet, 347 |
290–1 |
Granular dystrophy, 187–8 |
|
|
Fourth nerve, 516 |
inflammatory glaucoma, |
Graves eye disease. See |
|
|
disorders, 550, 551 |
281–2 |
Thyroid eye disease |
|
|
Frequency doubling |
intraocular pressure, 263 |
(TED) |
|
|
perimetry (FDP), 56 |
lowering agents, |
Graves’ disease, 475 |
|
|
Fuchs’ endothelial dystrophy |
pharmacology of, |
Gyrate atrophy, 462–3 |
|
|
(FED), 191–2 |
292–4 |
H |
|
|
Fuchs’ heterochromic |
laser procedures for, |
|
|
|
iridocyclitis (FHI), |
295–7 |
|
|
|
283, 327 |
lens-related glaucoma, |
Haemophilus, 621–2 |
|
|
Functional visual loss, |
284–5 |
Hamartomas, 637 |
|
|
569–70 |
neovascular glaucoma, |
Hansen disease. See Leprosy |
|
|
Fundus (chorioretinal) |
279–80 |
Hard lenses, 211 |
|
|
ophthalmic signs, 671–2 |
normal-tension glaucoma, |
Hardy–Rand–Rittler |
|
|
Fundus albipunctatus, 458 |
271–2 |
plates, 11 |
|
|
Fungal keratitis, 172–3 |
ocular hypertension, |
Hashimoto’s thyroiditis, 475 |
|
|
clinical features, 172 |
267–8 |
Headache, 655–6 |
|
|
investigation, 172–3 |
physiology, 262–3 |
Heerfordt’s syndrome, 339 |
|
|
risk factors, 172 |
phacolytic, 231 |
Heidelberg retinal |
|
|
treatment, 173 |
phacomorphic, 230 |
tomography (HRT), 66 |
|
|
Fungal uveitis |
pigment dispersion |
contraindications, 66 |
|
|
aspergillosis, 366 |
syndrome, 277 |
indications, 66 |
|
|
candidiasis, 366 |
primary angle-closure |
interpretation, 66 |
|
|
histoplasmosis and POHS, |
glaucoma, 273–4 |
method, 66 |
|
|
367 |
primary open-angle |
results, 66 |
|
|
G |
glaucoma, 269–70 |
Hematological disease |
|
|
pseudoexfoliation |
anemia, 451 |
|
|
|
syndrome, 275 |
hemoglobinopathies, |
|
|
|
Gadolinium-enhanced |
secondary closed-angle |
450–1 |
|
|
scans, 77 |
glaucomas, 288–9 |
hyperviscosity, 451 |
|
|
Ganciclovir, 174–5, 347 |
secondary open-angle |
leukemia, 451 |
|
|
Gatifloxacin, 254, 308–9 |
glaucomas, 286–7 |
Hemispheric BVO, 442 |
|
|
Gaze-evoked nystagmus |
surgery, 298 |
Hemoglobinopathies, 450–1 |
|
|
(GEN), 558 |
triad, 265 |
Herpes simplex, 143 |
|
|
Genetic disorders of eye, |
Glaucoma drainage device |
Herpes simplex keratitis, |
|
|
604 |
(GDD) surgery, 308–9 |
174–6 |
|
|
chromosomal locations of |
Glaucoma secondary to lens |
blepharoconjunctivitis, |
|
|
gene, 605 |
subluxation/dislocation, |
174 |
|
|
inheritance patterns, 604 |
285 |
disciform keratitis, 176 |
|
|
Gentamicin, 168 |
Glipizide, 424 |
epithelial keratitis, 174–5 |
|
|
Ghost cell glaucoma, 286 |
Glitazone, 424 |
stromal keratitis, 175–6 |
|
|
Giant cell arteritis (GCA), |
Globe of eye, 600 |
Herpes simplex virus (HSV), |
|
|
524, 525 |
ophthalmic signs, 663 |
345 |
|
|
Giant papillary conjunctivitis, |
Glyburide, 424 |
neonatal conjunctivitis, |
|
|
215 |
Glycerol, 705 |
622 |
|
|
730 |
INDEX |
|
|
|
|
|
Herpes viral group (HSV, |
interpretation, 53 |
Fuchs’ heterochromic |
|
|
VZV, CMV) anterior |
Hyaloid remnants, 635 |
iridocyclitis, 283 |
|
|
uveitis, 326 |
Hydrodissection, 243 |
open-angle type, 281 |
|
|
keratouveitis, 349 |
Hydrogel (soft) lenses, 211 |
Posner–Schlossman |
|
|
Herpes zoster ophthalmicus |
Hydroxyamphetamine, 554 |
syndrome, 283 |
|
|
(HZO), 177–8 |
Hydroxychloroquine, 435 |
Infliximab, 335, 340, 709, |
|
|
keratitis, 177–8 |
Hyperfluorescence, 61, 64 |
710 |
|
|
systemic and cutaneous |
Hypertensive retinopathy, |
Insulin, 424 |
|
|
disease, 177 |
448–9 |
Interferon-α, 709, 710 |
|
|
|||
|
|
Herpetic Eye Disease Study |
chronic hypertension, 448 |
Intermediate uveitis, 333 |
|
|
|||
|
|
(HEDS), 174–5 |
malignant hypertension, |
associations of, 334 |
|
|
Hirschberg test, 30 |
448–9 |
clinical features, 333 |
|
|
Histoplasma capsulatum, 367 |
Hyperviscosity, 451 |
treatment, 333 |
|
|
Histoplasmosis and POHS, |
Hyphema, 100–1 |
Intermittent exotropia, |
|
|
367 |
high-risk features in, 101 |
586–7 |
|
|
History of presenting illness |
Hypofluorescence, 61, 64 |
Internuclear |
|
|
(HPI), 2, 66 |
Hypoxia, 610 |
ophthalmoplegia (INO), |
|
|
HIV-associated disease, |
I |
544, 559 |
|
|
349–51 |
Intracapsular cataract |
|
|
|
anterior uveitis, 351 |
extraction (ICCE), 246 |
|
|
|
CD4 level and typical |
Iatrogenic glaucoma, 290–1 |
Intracranial bleeding, 610 |
|
|
diseases, 350 |
Idiopathic intracranial |
Intraocular-foreign body |
|
|
CMV retinitis, 352 |
hypertension, 533, 534 |
(IOFB), 95–6, 97–8 |
|
|
conjunctival |
Idiopathic juxtafoveal retinal |
removal, 98 |
|
|
microvasculopathy, 349 |
telangiectasia, 453 |
Intraocular lens (IOL), 239, |
|
|
cryptococcus choroiditis, |
Idiopathic orbital |
240, 245, 247–8 |
|
|
353 |
inflammatory disease, |
anterior chamber |
|
|
HIV microvasculopathy, |
483 |
intraocular lens |
|
|
353 |
Idiopathic polypoidal |
(ACIOL), 248 |
|
|
immune recovery uveitis, |
choroidal vasculopathy |
choice of lens, 247 |
|
|
353 |
(IPCV), 453–4 |
posterior chamber |
|
|
keratouveitis, 349 |
IgA nephropathy, 328 |
intraocular lens |
|
|
mycobacterium |
Illumination filters, 13–14 |
(PCIOL), 247–8 |
|
|
tuberculosis, 351 |
Image blurring, from |
Intraocular pressure (IOP), |
|
|
ophthalmic complications, |
refractive error, 576 |
262–3, 648 |
|
|
350 |
Immune recovery uveitis, |
-lowering agents, |
|
|
Pneumocystis carinii |
353 |
pharmacology of, |
|
|
choroiditis, 352–3 |
Immunoglobulin, 563 |
292–4 |
|
|
syphilis choroiditis/ |
Incominant strabismus, |
Intraocular tumors |
|
|
chorioretinitis, 353 |
588–9 |
astrocytoma, 509 |
|
|
toxoplasma |
mechanical, 588, 589 |
choroidal hemangiomas, |
|
|
retinochoroiditis, 352 |
myasthenic, 588 |
501 |
|
|
HLA-B27 |
myopathic, 589 |
circumscribed choroidal |
|
|
-associated AAU, 325 |
neurogenic, 588 |
hemangioma, 501 |
|
|
-related arthropathies, |
Incontinentia pigmenti, 634 |
diffuse choroidal |
|
|
329–30 |
Indirect ophthalmoscope |
hemangioma, 501 |
|
|
Homonymous |
and scleral indentor, 23 |
Sturge–Weber |
|
|
definition of, 48 |
method, 23 |
syndrome, 502 |
|
|
hemianopia, 49 |
optical features, 23 |
choroidal melanoma, |
|
|
Horizontal gaze palsy, 544 |
scleral indentation, 23 |
497–9 |
|
|
Horner’s syndrome, 554 |
Indocyanine green |
clinical features, 497 |
|
|
causes of, 555 |
angiography (ICG), 63 |
differential diagnosis, 498 |
|
|
investigations of, 555 |
contraindications, 63 |
investigations, 498 |
|
|
Hudson–Stahli line, 162 |
indications, 63 |
prognosis, 499 |
|
|
Human immunodeficiency |
interpretation, 63 |
treatment, 498 |
|
|
virus (HIV-1 and 2), |
method, 63 |
choroidal metastasis, |
|
|
349–51 |
side effects, 63 |
503–4 |
|
|
Human T-lymphotropic |
Infantile esotropia, 585 |
choroidal nevus, 500 |
|
|
virus type-1 (HTLV-1), |
Infantile exotropia, 586 |
choroidal osteoma, 503 |
|
|
346 |
Inflammatory glaucoma, |
ciliary body tumors |
|
|
Humphrey perimetry, 53 |
281–2 |
ciliary body melanoma, |
|
|
Humphrey visual field, 53 |
angle closure type, 282 |
496 |
732 |
INDEX |
|
|
|
|
|
age of onset, 232 |
Leptospira interrogans, 359 |
cicatricial, 119 |
|
|
clinical presentations, |
Leukemia, 451 |
congenital, 120 |
|
|
230–1 |
Leukocoria, 617 |
involutional, 119 |
|
|
grade, 232 |
Levator palpebrae superioris |
upper lid, 120 |
|
|
maturity of cataract, 232 |
(LPS), 106, 516 |
examination, 34–5 |
|
|
morphology, 232 |
Levocabastine, 146 |
Cogan’s twitch, 34 |
|
|
pathogenesis, 230 |
Levothyroxine, 482 |
fatiguability, 34 |
|
|
risk factors, 230 |
Lid apraxia, 568 |
jaw-winking, 35 |
|
|
types, 233 |
Lid lacerations, 90 |
normal lid |
|
|
cataract surgery |
assessment, 90 |
measurements, 35 |
|
|
assessment for, 234–5 |
repair for, 91 |
eyelash disorders, 108 |
|
|
complications, 251–3 |
specific features in |
lash infestations, 108 |
|
|
and concurrent eye |
assessment of, 90 |
lash poliosis, 108 |
|
|
disease, 249–50 |
treatment, 90 |
madarosis, 108 |
|
|
consent and planning, |
Lid lumps |
misdirected lashes, 108 |
|
|
236–7 |
anterior lamella, 112 |
lid lumps |
|
|
perioperative, 239–40 |
basal cell carcinoma, 115 |
anterior lamella, 112 |
|
|
postoperative, 241 |
benign tumors, 114 |
basal cell carcinoma, 115 |
|
|
extracapsular cataract |
Kaposi’s sarcoma, 116 |
benign tumors, 114 |
|
|
extraction, 246 |
malignant melanoma, 116 |
Kaposi’s sarcoma, 116 |
|
|
intracapsular cataract |
Merkel cell carcinoma, 116 |
malignant melanoma, |
|
|
extraction, 246 |
posterior lamella, 112–13 |
116 |
|
|
intraocular lenses, 247–8 |
premalignant tumors, 114 |
Merkel cell carcinoma, |
|
|
choice of, 247 |
sebaceous gland |
116 |
|
|
posterior chamber |
carcinoma, 115–16 |
posterior lamella, |
|
|
intraocular lens, |
squamous cell carcinoma |
112–13 |
|
|
247–8 |
(SCC), 115 |
premalignant tumors, |
|
|
anterior chamber |
Lidocaine, 690 |
114 |
|
|
intraocular lens, 248 |
Lidocaine/phe-nylephrine, |
sebaceous gland |
|
|
ophthalmic signs, 670 |
325 |
carcinoma, 115–16 |
|
|
optical properties of, 26 |
Lid retraction, 125 |
squamous cell |
|
|
physiology, 228–9 |
causes, 125 |
carcinoma, 115 |
|
|
phacoemulsification, |
Lid retractors, 106 |
ophthalmic signs, 664 |
|
|
242–3, 244–5 |
Lids |
ptosis |
|
|
continuous curvilinear |
acquired lid disorders, 124 |
acquired, 121–2 |
|
|
capsulorhexis, 242–3 |
anatomy and physiology, |
congenital, 123 |
|
|
hydrodissection, 243 |
104, 105 |
Ligneous conjunctivitis, 152 |
|
|
incision, 242 |
arterial supply, 107 |
Lipid keratopathy |
|
|
intraocular lens, 245 |
canthal tendons, 106 |
primary, 181 |
|
|
irrigation and aspiration, |
conjunctiva, 106 |
secondary, 181–2 |
|
|
245 |
fat pads, 106 |
Lipid metabolism disorders, |
|
|
ophthalmic viscosurgical |
lid retractors, 106 |
641 |
|
|
devices, 242 |
lymphatic drainage, 107 |
Locked-in syndrome, 545 |
|
|
preparation, 242 |
nerves, 107 |
Lodoxamide, 146 |
|
|
wound closure, 245 |
orbicularis oculi, 104 |
Lofgren’s syndrome, 339 |
|
|
postoperative cystoid |
orbital septum and tarsal |
LogMAR charts, 7 |
|
|
macular edema |
plates, 106 |
schematic example of, 8 |
|
|
Irvine–Gass syndrome, |
skin and eyelashes, 104 |
Low vision, 678–9 |
|
|
257 |
venous drainage, 107 |
assessment, 678 |
|
|
postoperative |
blepharitis, 110–1 |
management, 679 |
|
|
endophthalmitis |
bacterial blepharitis, 110 |
Lyme disease, 359–60 |
|
|
acute postoperative |
meibomianitis, 110 |
Lymphangioma, 489 |
|
|
endophthalmitis, |
seborrheic blepharitis, |
Lymphatic drainage, 107 |
|
|
254–5 |
111 |
Lymph nodes, ophthalmic |
|
|
chronic postoperative |
congenital lid disorders, 124 |
signs, 663 |
|
|
endophthalmitis, 255 |
ectropion, 117–18 |
Lymphoproliferative tumors |
|
|
presbyopia correcting |
cicatricial, 117 |
benign reactive lymphoid |
|
|
strategies, 238 |
congenital, 118 |
hyperplasia, 490 |
|
|
accomodative lens, 238 |
involutional, 117 |
langerhans cell |
|
|
multifocal lenses, 238 |
mechanical, 117 |
histiocytosis, 490 |
|
|
-related glaucoma, 284–5 |
paralytic, 118 |
malignant orbital |
|
|
Leprosy, 355–6 |
entropion, 119–20 |
lymphoma, 490 |
|
|
INDEX |
735 |
|
dystonias, 568 |
Neurotrophic keratopathy, |
Ocular pain, 656 |
|
|
fourth nerve disorders, |
200 |
Ocular trauma, 80–1 |
|
|
550, 551 |
Nevi, 114 |
Oculopharyngeal dystrophy, |
|
|
functional visual loss, |
Nodular non-necrotizing |
565 |
|
|
569–70 |
scleritis, 222 |
Ofloxacin, 141, 168 |
|
|
Horner’s syndrome, 554 |
Nonproliferative diabetic |
Oguchi’s disease, 458 |
|
|
causes of, 555 |
retinopathy (NPDR), 421 |
Older child |
|
|
investigations of, 555 |
Nonrefractive contact |
conjunctivitis in, 622 |
|
|
idiopathic intracranial |
lenses, 214 |
recognition tests for, 9 |
|
|
hypertension, 533, 534 |
Nonrefractive esotropia, |
Onchocerca volvulus, 365 |
|
|
|
|
|||
involuntary facial movement |
584 |
Onchocerciasis, 365 |
|
|
disorders, 568 |
Normal/near normal vision, |
One-and-a-half syndrome, |
|
|
Leber’s hereditary optic |
648 |
544 |
|
|
neuropathy (LHON), |
Normal-tension glaucoma |
Ophthalmia neonatorum, |
|
|
528 |
(NTG), 271–2 |
621–2 |
|
|
lid apraxia, 568 |
North Carolina macular |
Ophthalmic history, |
|
|
neuromuscular junction |
dystrophy, 461 |
obtaining, 2–4 |
|
|
disorders, 562–4 |
Nutritional and toxic optic |
Ophthalmic radiology |
|
|
myasthenia gravis (MG), |
neuropathies, 528 |
computerized |
|
|
562–3 |
Nutrition and nerve supply, |
tomography, 75–6 |
|
|
Lambert–Eaton |
161 |
dacryocystography, 75 |
|
|
myasthenic |
Nystagmus, 557, 661–2 |
magnetic resonance |
|
|
syndrome, 564 |
classification, 557 |
angiography, 78 |
|
|
optic atrophy, 529 |
early onset, 661 |
magnetic resonance |
|
|
inherited, 528–9 |
early-onset/congenital |
imaging, 77 |
|
|
optic neuropathy, |
nystagmus, 557 |
magnetic resonance |
|
|
assessment of, 519–20 |
late onset, 661–2 |
venography, 78 |
|
|
optic neuritis, assessment |
late-onset or acquired |
X-ray orbits, 75–6 |
|
|
of, 522–3 |
nystagmus, 558 |
Ophthalmic signs |
|
|
migraine, 541–2 |
treatment, 560 |
anterior segment, 665–6 |
|
|
myopathies, 565–6 |
O |
external, 663–4 |
|
|
chronic progressive |
posterior segment, 671–2 |
|
|
|
external |
visual fields, 675–6 |
|
|
|
ophthalmoplegia, 565 Ocular anesthesia, 690–1, |
Ophthalmic |
|
|
|
myotonic dystrophy, 566 |
692 |
ultrasonography, 57, |
|
|
oculopharyngeal |
peribulbar block, 690–1 |
58–9 |
|
|
dystrophy, 565 |
Subtenon’s block, 690 |
A-scans, 57 |
|
|
nutritional and toxic optic |
topical anesthesia, 690 |
B-scans, 58 |
|
|
neuropathies, 528 |
Ocular cicatricial |
Doppler ultrasound, 59 |
|
|
nystagmus, 557 |
pemphigoid (OCP), 148 |
Ophthalmic viscosurgical |
|
|
classification, 557 |
Ocular hypertension |
devices (OVDs), 242, |
|
|
early-onset/congenital |
(OHT), 267–8 |
243 |
|
|
nystagmus, 557 |
Ocular medication, 696–7 |
Optical coherence |
|
|
late-onset or acquired |
intravitreal injection, 697 |
tomography (OCT), |
|
|
nystagmus, 558 |
subconjunctival injection, |
65–6, 323 |
|
|
treatment, 560 |
696 |
indications, 65 |
|
|
papilledema, 530–2 |
subtenon and peribulbar |
interpretation, 66 |
|
|
pseudopapilledema, 532 |
injections, 697 |
method, 65 |
|
|
retrochiasmal disorders, |
topical, 696 |
results, 65 |
|
|
539–40 |
Ocular motility examination, |
Optic atrophy, 529 |
|
|
saccadic oscillations, 561 |
29–30 |
inherited, 528–9 |
|
|
saccadic intrusions, 561 |
caloric tests, 32 |
Optic chiasm of, 514 |
|
|
sixth nerve disorders, |
corneal reflection tests, 30 |
Optic disc, ophthalmic |
|
|
552, 553 |
cover tests, 30 |
signs, 674 |
|
|
supranuclear eye |
general approach, 29 |
Optic disc coloboma, 536 |
|
|
movement disorders, |
Maddox tests, 31 |
Optic disc pit, 535 |
|
|
543–5 |
Parks–Bielschewsky 3-step |
Optic fissure, abnormalities |
|
|
horizontal gaze, |
test, 32 |
in, 635 |
|
|
disorders of, 544–5 |
Ocular motor nerves, 517 |
Optic nerve, 514, 602 |
|
|
vertical gaze palsies, 546 |
Ocular mucous membrane |
Optic nerve anomalies, 636 |
|
|
third nerve disorders, |
pemphigoid (OMMP), |
Optic nerve avulsion, 93 |
|
|
547–9 |
148 |
Optic nerve glioma, 487–8 |
|
|
